Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term effects of initial bridging therapy with prednisolone in early rheumatoid arthritis
DRKS00030294Phase 4Completed
- Sponsor
- Ruhr University Bochum
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisolone in rheumatoid arthritis (RA) (3 arms), sponsored by Ruhr University Bochum. Started Sep 2022; status: completed.
02
Drugs
prednisolone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on DRKS00030294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00030294.